summary
Introduced
07/17/2025
07/17/2025
In Committee
07/17/2025
07/17/2025
Crossed Over
Passed
Dead
Introduced Session
119th Congress
Bill Summary
A BILL To protect an individuals ability to access medicines approved by the Food and Drug Administration to protect a health care providers ability to provide such medicines, and information related to such medicines.
AI Summary
This bill establishes a comprehensive legal framework to protect individuals' and healthcare providers' rights to access and provide FDA-approved medicines. The legislation defines FDA-approved medicines as drugs approved by the Food and Drug Administration (FDA) under specific federal statutes and broadly defines healthcare providers to include various medical professionals. The bill creates a statutory right for individuals to obtain FDA-approved medicines without coercion and for healthcare providers to prescribe and provide information about these medicines. It prohibits government entities (at federal and state levels) from implementing restrictions that would impede access to FDA-approved medicines or single out specific medicines, providers, or facilities. The bill includes strong enforcement mechanisms, allowing both the Attorney General and private individuals to file civil actions against entities that violate the law, with provisions for equitable relief and mandatory attorney's fees for prevailing plaintiffs. Importantly, the bill overrides other potential legal barriers, including the Religious Freedom Restoration Act, and explicitly states that it does not affect health insurance coverage requirements. The legislation is designed to be broadly protective, with a liberal interpretation clause instructing courts to construe the law's provisions to maximize access to FDA-approved medicines and related healthcare services.
Committee Categories
Business and Industry
Sponsors (28)
Deborah Ross (D)*,
Joyce Beatty (D),
Kathy Castor (D),
Yvette Clarke (D),
Steve Cohen (D),
Angie Craig (D),
Suzan DelBene (D),
Mark DeSaulnier (D),
Sarah Elfreth (D),
Veronica Escobar (D),
Lizzie Fletcher (D),
Lois Frankel (D),
Jahana Hayes (D),
Julie Johnson (D),
Timothy Kennedy (D),
Ted Lieu (D),
April McClain-Delaney (D),
Jenn McClellan (D),
Grace Meng (D),
Scott Peters (D),
Mary Gay Scanlon (D),
Kim Schrier (D),
Marilyn Strickland (D),
Dina Titus (D),
Lori Trahan (D),
Marc Veasey (D),
Bonnie Watson Coleman (D),
Nikema Williams (D),
Last Action
Referred to the House Committee on Energy and Commerce. (on 07/17/2025)
Taxonomy
Health
- ‐ Regulation of Doctors and Health Facilities
- ‐ Regulation of Drug Industry and Pharmacies
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location | Created |
|---|---|---|
| State Bill Page | https://www.congress.gov/bill/119th-congress/house-bill/4525/all-info | 07/18/2025 |
| BillText | https://www.congress.gov/119/bills/hr4525/BILLS-119hr4525ih.pdf | 07/30/2025 |
Loading...